-- Applied BioCode（TPE:6598）の米国法人は、同社の呼吸器病原体パネルについて、米国食品医薬品局（FDA）から510(k)承認を取得したと、月曜日に台湾証券取引所に提出した書類で明らかにした。 この承認により、同社のパネルはBioCode MDx 3000システムとThermo Fisher ScientificのKingFisher抽出プラットフォームとの組み合わせで使用可能となり、既存のbioMérieuxおよびRocheのシステムとの互換性がさらに向上する。 同社は、この承認により米国での複合ソリューションの販売が可能になり、検査機関は抽出システムにおいてより柔軟な選択肢を得られるようになり、事業および財務実績の向上に貢献すると見込んでいる。
Related Articles
Asia
Market Chatter: Coles CEO Says Grocery Price Increases 'Inevitable' Amid Fuel Cost Surge
Coles Group (ASX:COL) Chief Executive Leah Weckert said price hikes for groceries are "inevitable" as the supermarket chain and its suppliers deal with higher fuel costs, Bloomberg reported Monday.Speaking at an Australian Shareholders' Association conference in Melbourne, Weckert said that the trend is showing up in supermarket data, with shoppers opting for beef mince or chicken over steak, while also making fewer trips to stores to cut fuel costs.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
$ASX:COL
Asia
Singapore Airlines to Deploy Starlink Broadband Services in 2027
Singapore Airlines (SGX:C6L) will deploy Starlink's low-earth-orbit satellite-based broadband service on its planes, starting from the first quarter of 2027, according to a company release on Monday.The service will be available to all cabin classes on Starlink-enabled aircraft.
$SGX:C6L
Asia
iX Biopharma Secures Listing and Quotation Notice for New Shares; Shares Zoom 11%
iX Biopharma (SGX:42C) received a listing and quotation notice from the Singapore Exchange Securities Trading for 1.3 million shares, according to a Thursday filing with the Singapore Exchange.Shares of the pharmaceutical and nutraceutical company surged nearly 11% in Monday trading.The notice is subject to shareholder approval and compliance with the bourse's listing requirements, the filing added.
$SGX:42C